Pharma Stocks
-
Is Xspray Pharma (STO:XSPRAY) In A Good Position To Deliver On Growth Plans?
There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses…
Read More » -
Defensive Pharma Heavyweight Weighs Litigation Risks Against Pipeline Promise
GSK’s stock has drifted sideways in recent sessions, caught between renewed confidence in its vaccines and HIV franchises and a…
Read More » -
60 Degree Pharmaceuticals Announces One-for-Four Reverse Stock Split Effective January 20, 2026
WASHINGTON, Jan. 15, 2026 (GLOBE NEWSWIRE) — 60 Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”),…
Read More » -
Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett…
Read More » -
Marksans Pharma Limited’s (NSE:MARKSANS) Shares May Have Run Too Fast Too Soon
It’s not a stretch to say that Marksans Pharma Limited’s (NSE:MARKSANS) price-to-earnings (or “P/E”) ratio of 22.2x right now seems…
Read More » -
A Look At BridgeBio Pharma (BBIO) Valuation After New ATTR-CM, LGMD2I/R9 And TTR Antibody Updates
Why BridgeBio Pharma stock is back in focus BridgeBio Pharma (BBIO) has returned to the spotlight after management outlined fresh…
Read More » -
LIC raises stake in Sun Pharma to 5.04%. Details here
Life Insurance Corporation of India (LIC), insurance behemoth and India’s biggest institutional investor, raised its stake in the pharma company…
Read More » -
A Look At Ligand Pharmaceuticals (LGND) Valuation As Royalty Growth And Investment Plans Take Focus
Royalty growth outlook and capital deployment signal focus areas for investors Ligand Pharmaceuticals (LGND) recently highlighted an expected 40% royalty…
Read More » -
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13
NEW YORK, Jan 13, 2026, 14:32 (EST) — Regular session Shares of LGND dropped roughly 11% following the FDA’s decision…
Read More » -
Acadia sees $1.7B 2028 sales, pipeline updates
Key Terms phase 2 medical Phase 2 is the mid-stage clinical trial where a new drug or treatment is tested…
Read More »